| Literature DB >> 25554368 |
Anastasia Slobodnick1, Binita Shah2, Michael H Pillinger3, Svetlana Krasnokutsky1.
Abstract
Although colchicine has been a focus of research, debate, and controversy for thousands of years, the US Food and Drug Administration just approved it in 2009. Over the past decade, advances in the knowledge of colchicine pharmacology, drug safety, and mechanisms of action have led to changes in colchicine dosing and to potential new uses for this very old drug. In this review, we discuss the pharmacologic properties of colchicine and summarize what is currently known about its mechanisms of action. We then discuss and update the use of colchicine in a variety of illnesses, including rheumatic and, most recently, cardiovascular diseases. Published by Elsevier Inc.Entities:
Keywords: Cardiovascular disease; Colchicine; Gout; Inflammation
Mesh:
Substances:
Year: 2014 PMID: 25554368 PMCID: PMC4684410 DOI: 10.1016/j.amjmed.2014.12.010
Source DB: PubMed Journal: Am J Med ISSN: 0002-9343 Impact factor: 4.965